Quasi-blind tumor drug test device based on microfluidic technology
By designing a device-like blind tumor drug testing device based on microfluidic control technology, the problems of high manufacturing cost and complex operation of microfluidic chips are solved, the drug ratio is automated and the test tubes are stable, and the experiment accuracy is improved and efficiency, adapt to different types of test tube needs.
Patent Information
- Application Number
- CN202323600213.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-28
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2033-12-28
AI Technical Summary
The existing microfluidic chips are cost-effective in manufacturing, complex in operation, easy to contaminate and block, the traditional test tube fixation method is inconvenient and poor adaptability, and cannot meet the needs of different types of test tubes.
A device-like blind tumor drug testing device based on microfluidic control technology is designed, including a microfluidic control box, a medicine tray, a preparation box, a medicine discharge pipe and a mounting frame mechanism, using a detachable observation window and elastic The docking plug and bright light belt realizes automated and precise control of the drug ratio, and fixes the test tube through the mounting frame mechanism and limit clamp to provide stable and safe support.
It improves the accuracy and efficiency of drug ratio, reduces the dosage of drugs, enhances the stability and safety of test tubes, reduces the risk of test tube damage, and adapts to the needs of different types of test tubes.
Smart Images

Figure CN221951256U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of drug microfluidics, in particular to an organ-blind tumor drug testing device based on microfluidics technology. Background Art
[0002] Microfluidics is a new type of precise fluid control technology that has emerged in recent years and is widely used in chemical analysis, drug screening, biological detection and other fields. In traditional chemical experiments, it is often necessary to manually perform multiple operations such as drug ratio and reaction condition control, which is time-consuming, labor-intensive and prone to errors. Microfluidics can achieve flow control of microscopic particles such as tiny droplets or bubbles by precisely controlling parameters such as flow rate, pressure and volume in microchannels, and realize high-throughput and high-precision rapid combination of reagents.
[0003] However, existing microfluidic chips have high manufacturing costs, are not convenient for large-scale production, and require professional technicians to operate. In addition, since microfluidic technology requires the use of tiny flow channels and micro devices, it is easily affected by problems such as contamination and clogging, which puts higher requirements on the cleaning and maintenance of the equipment.
[0004] Test tubes are bottle-shaped containers commonly used in chemical experiments, and their stability and support are one of the key factors. Traditional test tube fixing methods are mainly hand-held or bracket-based fixing methods. This method is inconvenient to operate, and the test tubes are prone to shaking and tilting, which may lead to inaccurate experimental results or equipment damage. At the same time, traditional test tube racks also have various shapes, sizes, etc., and have poor adaptability to test tubes, and cannot meet the needs of different types of test tubes.
[0005] To this end, we proposed an organ-blind tumor drug testing device based on microfluidic technology. Utility Model Content
[0006] The utility model mainly solves the technical problems in the background technology and provides an organ-blind tumor drug testing device based on microfluidic technology.
[0007] In order to achieve the above-mentioned purpose, the utility model adopts the following technical scheme: an organ-blind tumor drug testing device based on microfluidic technology, including a microfluidic control box body, wherein the two ends of the microfluidic control box body are respectively connected to a drug placement table and a preparation box body, and the front end wall of the preparation box body is hollowed out, wherein the hollow front end of the preparation box body is provided with a detachable observation window, and a pluggable medicine bottle is provided on the drug placement table, and the output ends of the microfluidic control box body are respectively connected to an output channel and a drug discharge pipe, and the other end of the drug discharge pipe extends from the top of the preparation box body to the interior thereof, and the interior of the preparation box body is provided with a mounting frame mechanism located directly below the lower end outlet of the drug discharge pipe, and a test tube body is detachably provided on the mounting frame mechanism, and the bottom of the test tube body is butted against the bottom of the drug discharge pipe.
[0008] Preferably, fifteen medicine entry grooves are provided on the top of the medicine placing table, and each medicine bottle is inverted and the bottle mouth is inserted into the corresponding medicine entry groove.
[0009] Preferably, the drug discharge tube is an L-shaped structure with a hollow interior, and fifteen groups of micro-catheters corresponding to the drug entry grooves are arranged inside the drug discharge tube. The lower end of the drug discharge tube is connected to an elastic docking plug, which is inserted into the top opening of the test tube body, and each micro-catheter is connected to the interior of the docking plug.
[0010] Preferably, the mounting frame mechanism comprises a C-shaped limiting clamp located on the top, and a bracket is connected between the limiting clamp and the mounting frame mechanism.
[0011] Preferably, the mounting frame mechanism adopts an elastic concave disc.
[0012] Preferably, the mounting frame mechanism further comprises a strong light strip located on the inner side of the bracket.
[0013] Preferably, an operation panel and a display screen are distributed on the front end of the microfluidic control box body.
[0014] Preferably, an L-shaped handle is provided at the connection between the microfluidic control box body and the top of the medicine placing table.
[0015] Preferably, a card slot is provided on the bottom of the front end of the preparation box body extending outward, and an observation window is inserted into the card slot to seal the hollow part of the front end of the preparation box body.
[0016] The utility model provides an organ-blind tumor drug testing device based on microfluidic technology. It has the following beneficial effects:
[0017] (1) Compared with the traditional manual operation method, the microfluidic-based device for blind tumor drug testing uses microfluidic technology to achieve automated and precise control of drug ratios. This improvement can improve the accuracy, repeatability and efficiency of the experiment and save the amount of drugs. By adopting the design of the mounting frame mechanism and the limit clamp: By adopting the structure of the mounting frame mechanism and the limit clamp, the test tube body can be stably fixed and elastic support and protection can be provided for the bottom of the test tube. This improvement can increase the stability and safety of the test tube and reduce the risk of damage to the test tube. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] In order to more clearly illustrate the implementation of the utility model or the technical solution in the prior art, the following is a brief introduction to the drawings required for the implementation or the prior art description. Obviously, the drawings in the following description are only exemplary, and for ordinary technicians in this field, other implementation drawings can be derived from the provided drawings without creative work.
[0019] The structures, proportions, sizes, etc. illustrated in this specification are only used to match the contents disclosed in the specification so as to facilitate understanding and reading by persons familiar with the technology. They are not used to limit the conditions under which the present invention can be implemented, and therefore have no substantial technical significance. Any structural modification, change in proportion or adjustment of size shall still fall within the scope of the technical contents disclosed in the present invention without affecting the effects and purposes that can be achieved by the present invention.
[0020] Figure 1 It is the overall schematic diagram of the device of the utility model;
[0021] Figure 2 This is a schematic diagram of a half-section structure of the device of the utility model;
[0022] Figure 3 It is a partial schematic diagram of the installation frame mechanism and the drug discharge pipe of the utility model;
[0023] Figure 4 It is an independent schematic diagram of the mounting frame mechanism of the utility model;
[0024] Figure 5 It is a schematic diagram of the drug discharge pipe of the utility model.
[0025] Legend:
[0026] 1. Microfluidic control box body; 101. Operation panel; 102. Display screen; 2. Medicine placing table; 201. Medicine entry groove; 202. Medicine bottle; 3. Preparation box body; 301. Card slot; 302. Observation window; 4. Medicine discharge tube; 401. Docking plug; 402. Micro catheter; 5. Mounting frame mechanism; 501. Bracket; 502. Limit clamp; 503. High light belt; 6. Test tube body; 7. Output channel. DETAILED DESCRIPTION
[0027] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.
[0028] Embodiment: A device for testing tumor drugs based on microfluidics technology, such as Figure 1-Figure 5As shown, it includes a microfluidic control box body 1, the two ends of which are respectively connected to a drug placement table 2 and a preparation box body 3, the front end wall of the preparation box body 3 is hollowed out, wherein a detachable observation window 302 is provided at the hollow front end of the preparation box body 3, a pluggable medicine bottle 202 is provided on the drug placement table 2, the output end of the microfluidic control box body 1 is respectively connected to an output channel 7 and a drug discharge pipe 4, the other end of the drug discharge pipe 4 extends from the top of the preparation box body 3 to the inside thereof, and the inside of the preparation box body 3 is provided with a mounting frame located just below the outlet of the lower end of the drug discharge pipe 4 The mounting frame mechanism 5 is provided with a test tube body 6 detachably, and the bottom of the test tube body 6 is butted with the bottom of the drug discharge tube 4; the mounting frame mechanism 5 includes a C-shaped limiting clamp 502 located on the mounting frame mechanism 5, and a bracket 501 is connected between the limiting clamp 502 and the mounting frame mechanism 5; the mounting frame mechanism 5 adopts an elastic concave disc; the elastic mounting frame mechanism 5 is adopted, when the test tube body 6 is placed on the groove of the mounting frame mechanism 5, the bottom of the test tube body 6 can be elastically supported, so that the test tube body 6 can be stably and safely limited on the mounting frame mechanism 5. The C-shaped structure of the limiting clamp 502 also facilitates the fixing and installation of the test tube body 6.
[0029] The mounting frame mechanism 5 also includes a strong light strip 503 located on the inner side of the bracket 501. By vertically arranging the strong light strip 503 on the inner side of the bracket 501, the mixed reagent inside the test tube body 6 can be illuminated, making it convenient for the inspector to observe the mixed state of the reagent inside the test tube body 6.
[0030] Among them, Figure 2 As shown, the top of the medicine placing table 2 in this solution is provided with fifteen medicine entry grooves 201, and each medicine bottle 202 is inverted and inserted into the corresponding medicine entry groove 201 with the bottle mouth, which can adapt to multiple groups of different medicines for proportioning experiments.
[0031] Specific as Figure 1 , Figure 2 , Figure 3 and Figure 5 The drug discharge tube 4 is an L-shaped structure with a hollow interior, and fifteen groups of micro-catheters 402 corresponding to the drug entry grooves 201 are arranged inside the drug discharge tube 4. The lower end of the drug discharge tube 4 is connected to an elastic docking plug 401, which is inserted into the top opening of the test tube body 6, and each micro-catheter 402 is connected to the interior of the docking plug 401.
[0032] The front end of the microfluidic control box body 1 is provided with an operation panel 101 and a display screen 102; the microfluidic control box body 1 of the device is controlled by controlling the operation panel 101, and the medicine bottle 202 inserted into the medicine entry groove 201 is controlled to be input into the test tube body 6 from the medicine discharge pipe 4 along the output channel 7.
[0033] An L-shaped handle 203 is provided at the connection between the microfluidic control box body 1 and the top of the medicine placing table 2; by providing the L-shaped handle 203 between the microfluidic control box body 1 and the top of the medicine placing table 2, the device can be conveniently carried and moved.
[0034] The working principle of the utility model is as follows: when in use, various types of experimental medicines are loaded into corresponding medicine bottles 202, and medicine bottles 202 are inverted and inserted into corresponding medicine entry grooves 201. A total of fifteen groups of medicine entry grooves 201 and medicine bottles 202 cooperate with each other, and are in an open structure at the top of the medicine placing table 2, which is convenient for plugging and unplugging the used medicine bottles 202 for replenishment and replacement, and is also convenient for mixing and proportioning more different medicines. A large number of groups are reserved, and then the test tube body 6 for the experimental configuration of medicines is made through the The hollow front end of the preparation box body 3 is inserted into the internal mounting frame mechanism 5, the docking plug 401 at the bottom of the drug discharge tube 4 is docked with the docking plug 401 at the upper end of the test tube body 6, and the matching medicine in the corresponding medicine bottle 202 is dripped from the micro-catheter 402 along the output channel 7 into the test tube body 6 for mixing. When the medicine is matched inside the test tube body 6, the detachable observation window 302 at the front end of the preparation box body 3 is inserted into the groove on the card slot 301 to seal it to avoid interference from dust and impurities in the external environment air.
[0035] As for the mounting frame mechanism 5 used for limiting the test tube body 6, an upper and lower mounting frame mechanism 5 and a limiting clamp 502 are used to fix and limit it. During installation, it is only necessary to insert and fix it through the C-shaped opening of the tube limiting clamp 502, and then place the bottom of the test tube body 6 on the elastic mounting frame mechanism 5, which has an elastic supporting and protective effect on the bottom of the test tube body 6. When conducting multiple groups of drug ratio experiments inside the test tube body 6, opening the strong light belt 503 on the inner side of the bracket 501 can also illuminate the inside of the test tube body 6, so that the technician can more clearly observe the mixed drug ratio state inside the test tube body 6.
[0036] After use, the power plug on the outside of the medicine placing table 2 can be removed, and the device can be moved to another location by holding the handle 203, so as to achieve a portable effect.
[0037] The above shows and describes the basic principle and main features of the utility model and the advantages of the utility model. Those skilled in the art should understand that the utility model is not limited by the above embodiments. The above embodiments and descriptions are only for explaining the principle of the utility model. Without departing from the spirit and scope of the utility model, the utility model may have various changes and improvements, which fall within the scope of the utility model to be protected. The scope of protection claimed by the utility model is defined by the attached claims and their equivalents.
Claims
1. A device for testing tumor drugs based on microfluidics, comprising a microfluidics control box body (1), Features: The two ends of the microfluidic control box body (1) are respectively connected to the drug placement table (2) and the preparation box body (3); the front end wall of the preparation box body (3) is hollowed out, wherein the hollowed-out front end of the preparation box body (3) is provided with a detachable observation window (302); a pluggable medicine bottle (202) is provided on the drug placement table (2); the output end of the microfluidic control box body (1) is respectively connected to the output channel (7) and the drug discharge pipe (4); the other end of the drug discharge pipe (4) extends from the top of the preparation box body (3) to the inside thereof; the inside of the preparation box body (3) is provided with a mounting frame mechanism (5) located directly below the lower end outlet of the drug discharge pipe (4); the mounting frame mechanism (5) is detachably provided with a test tube body (6); the bottom of the test tube body (6) is butted against the bottom of the drug discharge pipe (4).
2. The organ-blind tumor drug testing device based on microfluidic technology according to claim 1, Features: Fifteen medicine entry grooves (201) are provided on the top of the medicine placing table (2), and each medicine bottle (202) is inverted and inserted into the corresponding medicine entry groove (201) with the bottle mouth.
3. The organ-blind tumor drug testing device based on microfluidics technology according to claim 1, Features: The drug discharge tube (4) is an L-shaped structure with a hollow interior, and fifteen groups of micro-tubes (402) corresponding to the drug entry grooves (201) are arranged inside the drug discharge tube (4). The lower end of the drug discharge tube (4) is connected to an elastic docking plug (401), which is inserted into the top opening of the test tube body (6), and each micro-tube (402) is connected to the interior of the docking plug (401).
4. The organ-blind tumor drug testing device based on microfluidics technology according to claim 1, Features: The mounting frame mechanism (5) comprises a C-shaped limiting clamp (502) located on the top, and a bracket (501) is connected between the limiting clamp (502) and the mounting frame mechanism (5).
5. The organ-blind tumor drug testing device based on microfluidics technology according to claim 4, Features: The mounting frame mechanism (5) adopts an elastic concave disc.
6. The organ-blind tumor drug testing device based on microfluidics technology according to claim 4, Features: The mounting frame mechanism (5) further comprises a strong light strip (503) located inside the bracket (501).
7. The organ-blind tumor drug testing device based on microfluidics technology according to claim 1, Features: An operation panel (101) and a display screen (102) are arranged at the front end of the microfluidic control box body (1).
8. The organ-blind tumor drug testing device based on microfluidics technology according to claim 1, Features: An L-shaped handle (203) is provided at the connection between the microfluidic control box body (1) and the top of the medicine placing table (2).
9. The organ-blind tumor drug testing device based on microfluidics technology according to claim 1, Features: The front end of the preparation box body (3) extends outwards and a slot (301) is provided on the bottom. An observation window (302) is inserted into the slot (301) to seal the hollowed-out front end of the preparation box body (3).
